1 / 39

Thyroid and Parathyroid Pharmacology

Thyroid and Parathyroid Pharmacology. Thyroid Hormones. Thyroxine (T4, tetraiodothyronine) Liothyronine (T3, triiodothyronine) Iodinated diphenyl ether structure Built and stored on thyroglobulin >99% protein bound in plasma Only free form has physiologic effects

hop
Download Presentation

Thyroid and Parathyroid Pharmacology

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Thyroid and Parathyroid Pharmacology

  2. Thyroid Hormones • Thyroxine (T4, tetraiodothyronine) • Liothyronine (T3, triiodothyronine) • Iodinated diphenyl ether structure • Built and stored on thyroglobulin • >99% protein bound in plasma • Only free form has physiologic effects • T3 more potent; T4 longer lasting • Peripheral deiodination

  3. Physiological Effects • Increases transcription (nuclear) • Increases mitochondrial metabolism • Net effects are target dependent • Oxygen consumption • Heat production • Metabolism, growth, differentiation • Promotes effects of hormones • Steroids, catecholamines

  4. Thyroid Anatomy

  5. Thyroid Structure Hypothyroid Euthyroid Hyperthyroid

  6. Thyroid Biosynthesis

  7. Thyroid Biosynthesis • Iodide Trapping • Thyroglobulin Synthesis • Iodination • Coupling • Proteolysis to release T3/T4 • Deiodination and recycling

  8. Thyroid Biosynthesis

  9. Thyroid Gland Regulation + + Hypothalamus Anterior Pituitary Thyroid Gland TRH TSH Adenylyl Cyclase cAMP TSH Receptor - - T3/T4

  10. Hyperthyroidism • Causes • Grave’s disease (TSHR autoantibodies) • 0.1% to 1% prevalence, higher in women • Thyroiditis • Toxic adenoma • Non-pharmacologic treatments • Subtotal thyroidectomy • Radioiodine • Arterial embolization (2005)

  11. Case Report • 47 yo woman reports palpitations, tremulousness, weight loss, heat intolerance of 6 weeks duration • PE reveals HR = 110 bpm, BP = 150/70 a diffusely enlarged thyroid gland, fine tremor of outstretched hands and a wide-eyed stare • Lab reports free T4 = 40 pmol/L, free T3 = 10.6 pmol/L with undetectable TSH and elevated thyroid-stimulating globulins confirming a Dx of Grave’s disease

  12. Hyperthyroidism • Pharmacologic Treatments • Thionamides (thiourelynes)

  13. Hyperthyroidism • Methimazole (Tapazole) • Typical dose 15 – 30 mg QD • Rapidly absorbed (Cmax < 2 hours) • Half-life 13 – 18 hours • Propylthiouracil (PTU) • Typical dose 50– 600 mg BID • Good bioavailability • Half-life 2 – 4 hours • Blocks peripheral T4 -> T3 conversion

  14. Thionamide MOA Coupling is also highly sensitive to drug

  15. Thionamide Side Effects • Rash/itch • Fever • Rarely: • Liver dysfunction • Leucocytopenia

  16. Other Antithyroid Options • Iodide loading • High doses can inhibit iodide formation • Effect transient • May be useful prior to RAI or surgery • Debulk and devascularize gland • Side effects • Rash, hypersalivation, oral ulcers • CI in pregnancy (may cause fetal goiter)

  17. Other Antithyroid Options • Beta Blockers • Adjunctive treatment • May reduce T4 -> T3 conversion • Control HR and palpitations, sweats • Rapid action • Corticosteriods • Reduce T4 -> T3 conversion • May reduce TSHR antibody effect in Grave’s

  18. Case Report • Patient started on PTU 200 mg BIDand propranolol 40 mg TID, becoming euthyroid in 6 weeks whereupon the propranolol was tapered and D/C’d • Remained on maintenance PTU for one year (50 mg bid) then discontinued and remained well for 3 yrs • Symptoms recurred and PTU + propranolol was re-instituted for symptomatic relief. After 7 weeks, she developed a whole body red itchy rash • She received Na131I in a dose of 10 mCi by mouth for definitive control of her hyperthyroidism

  19. Thyroid Storm • Potentially life threatening • Combined treatment strategy • High dose PTU • Give 1st; iodide will reduce drug uptake in gland • Iodide loading (IV Lugol’s solution) • Beta blockers • Corticosteriods

  20. New Antithyroid Drug?

  21. Grave’s Disease Compound “1” TSHRab X + + Hypothalamus Anterior Pituitary Thyroid Gland TRH TSH X Adenylyl Cyclase cAMP TSH Receptor - - T3/T4

  22. New Antithyroid Drug?

  23. Hypothyroidism • Causes • Primary • Idiopathic • Autoimmune • Traumatic • Iatrogenic • Secondary • Pituitary dysfunction • Increased protein binding • estrogen; HIV; liver dysfunction; heroin

  24. Hypothyroidism • Treatment = Hormone Replacement • Synthetic T4 (synthroid) • Absorption fair (65%) • Half-life 5 – 7 days • Synthetic T3 (liothyronine) • Absorption good (>90%) • Half-life 1 – 2 days • Synthetic T4:T3 (Liotrix 4:1 ratio)

  25. Case Report • 3 months later, she returned with lethargy, fatigue, coldness at room temperature, puffiness around the eyes and constipation • Labs showed free T4 = 8 pmol/L, free T3 = 2 pmol/L and TSH = 8 mU/mL confirming hypothyroidism • Levothyroxine 0.1mg daily was instituted and after 6 weeks, blood tests showed a TSH level of 3.2 mU/mL and all symptoms had resolved • She has remained well on this regimen for 2 years

  26. Parathyroid Basics

  27. Parathyroid Basics • Parathyroid Hormone • Small molecule (34 amino acids) • Activity based on amino terminal • No disulfide linkages • Encoded on chromosome 11 • Half-life only 2 – 4 minutes • Secreted by chief cells

  28. Calcium Homeostasis • 3 Tissues • Bone • Kidney • Intestine • 3 Hormones • PTH • Calcitonin • Activated Vitamin D3 (1,25[OH]2-D3) • 3 Cells • Osteoblasts • Osteocytes • Osteoclasts

  29. Hypoparathyroidism • Decreased bone resorption & osteocytic activity • Hypocalcemia • Increased neuromuscular excitability • Tetanic muscle contractions/spasms • Seizure • Prolonged QT interval • Cataract • Trousseau Sign • Chvostek Sign • Low or absent iPTH

  30. Hypoparathyroidism • Causes • Surgical (most common) • Idiopathic • Genetic familial forms • Circulating receptor antibodies • Functional • Due to hypomagnesemia • Mg2+ necessary for PTH release

  31. Psuedohypoparathyroidism • Target organs resistant to PTH • Congential defect of PTHR1 • Plasma Ca2+ low • Plasma phosphate high • Renal phosphatase activity high

  32. Hypoparathyroidism • Maintenance Treatment • Combined oral calcium + Vitamin D • Phosphate restriction may be used • Acute Treatment • Tetany or Hungry Bone Syndrome • Parenteral calcium followed by vitamin D supp + oral calcium

  33. Hyperparathyroidism • Primary • Excess PTH high calcium, low phosphate • Tumor, adenoma, hyperplasia • More common in women • Marrow fibrosis • Osteitis fibrosa cystica • Metabolic acidosis • Increased Alk Phos (bone) • Kidney stones

  34. Hyperparathyroidism • Primary – Diagnosis • Multiple elevated Ca2+ serum tests • Elevated iPTH • Alk Phos typically low • Corticosteroid suppression test • Prednisolone reduces serum Ca2+ • Indicates non-parathyroid origin • Sarcoid, vitamin D intoxication, etc.

  35. Hyperparathyroidism • Treatment • Acute Severe forms • Adequate hydration, forced diuresis • Other Agents • Corticosteroids – Blood malignancies • Mythramycin • Toxic antibiotic used to inhibit bone resorption – hematologic and solid neoplasms

  36. Hyperparathyroidism • Treatment • Other Agents • Calcitonin • Inhibits osteoclast activity and bone resorption • Biphosphonates • Given IV or orally to reduce bone resorption • Estrogen • Can be given to postmenopausal women with 1° hyperparathyroidism as medical therapy

  37. Hyperparathyroidism • Treatment • Surgery • Definitive treatment

  38. 2° Hyperparathyroidism • Adaptive & unrelated to intrinsic disease of glands • Due to chronic stimulation of glands by low serum Ca2+ levels

  39. 2° Hyperparathyroidism • Causes • Dietary deficiency of vitamin D or Ca2+ • Decreased intestinal absorption of vitamin D or Ca2+ • Drugs such as phenytoin, phenobarbital • Renal Failure • Decreased activation of vitamin D3 • Hypomagnesemia

More Related